Evaluating the Influence of Ready-to-use (RTU) Parenteral Nutrition in the Clinical Outcome of Patients Study

NCT00798681 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 406

Last updated 2010-08-10

No results posted yet for this study

Summary

This is an international prospective randomized multicenter open-label controlled study. The primary center will be Fernandes Távora Hospital (Fortaleza, Ceará). The aim of this study is to investigate the effects of closed parenteral nutrition systems when compared to open parenteral nutrition systems in terms of several clinical outcomes.

Conditions

  • Parenteral Nutrition

Interventions

DIETARY_SUPPLEMENT

RTU TPN with olive oil as the primary lipid source

RTU will be provided as a 3 in 1 TPN ready-to-use TPN system in industrialized bags with 2.000 ml. The number of calories will be adjusted in accordance with patients' individual needs.

OTHER

CNF Parenteral nutrition

CNF parenteral nutrition made with olive oil as the primary source of lipids

OTHER

CNF parenteral nutrition

3 in 1 CNF parenteral nutrition made with LCT/MCT as the primary source of lipids

Sponsors & Collaborators

  • Hospital Bandeirantes

    collaborator OTHER
  • Hospital Santa Luzia

    collaborator UNKNOWN
  • Hospital Samaritano

    collaborator UNKNOWN
  • Hospital da Polícia Militar

    collaborator UNKNOWN
  • Sanatório Los Arcos

    collaborator UNKNOWN
  • Sanatório Trinidad Palermo

    collaborator UNKNOWN
  • Hospital Roosevelt

    collaborator UNKNOWN
  • Fernandes Tavora Hospital

    lead OTHER

Principal Investigators

  • Alessandro Pontes-Arruda, MD, MSc, PhD, FCCM · Fernandes Tavora Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Argentina
  • Brazil
  • Guatemala

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00798681 on ClinicalTrials.gov